To date, not only the CD8+ and FoxP3+ TIL counts but also the FCR has been reported as prognostic predictors in several malignancies, such as non-small cell lung carcinoma, breast cancer, and gastroenterological malignancies [28–30]. Here, FOXP3 is linked to breast carcinoma.